Forza X1, Inc.

$ Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000173112224001255 Filed on August 14, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$8.189M	$16.52M
YoY Change		-50.42%	6292.01%
Cash & Equivalents	$7.200M	$8.189M	$16.52M
Short-Term Investments		$0.00
Other Short-Term Assets		$73.51K	$158.8K
YoY Change		-53.71%	377.34%
Inventory	$60.65K	$273.1K	$522.0K
Prepaid Expenses
Receivables	$125.0K
Other Receivables
Total Short-Term Assets	$7.554M	$8.554M	$17.20M
YoY Change	-53.49%	-50.26%	5474.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.388M	$4.565M	$998.0K
YoY Change	317.16%	357.43%	163.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$7.520K	$7.520K
YoY Change		0.0%
Other Assets
YoY Change
Total Long-Term Assets	$4.403M	$4.603M	$1.125M
YoY Change	280.7%	309.32%	79.78%
TOTAL ASSETS
Total Short-Term Assets	$7.554M	$8.554M	$17.20M
Total Long-Term Assets	$4.403M	$4.603M	$1.125M
Total Assets	$11.96M	$13.16M	$18.32M
YoY Change	-31.28%	-28.19%	1861.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$73.07K	$503.6K	$79.12K
YoY Change	89.72%	536.58%	1353.84%
Accrued Expenses	$9.712K	$27.81K	$111.5K
YoY Change	-86.86%	-75.06%	168.63%
Deferred Revenue	$6.175K	$6.175K	$5.800K
YoY Change		6.47%
Short-Term Debt		$0.00	$104.0K
YoY Change		-100.0%	832.26%
Long-Term Debt Due		$24.54K	$17.02K
YoY Change		44.18%
Total Short-Term Liabilities	$113.8K	$585.2K	$406.9K
YoY Change	-49.73%	43.84%	599.94%
LONG-TERM LIABILITIES
Long-Term Debt		$73.40K	$67.72K
YoY Change		8.39%
Other Long-Term Liabilities			$23.07K
YoY Change
Total Long-Term Liabilities		$73.40K	$90.79K
YoY Change		-19.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$113.8K	$585.2K	$406.9K
Total Long-Term Liabilities		$73.40K	$90.79K
Total Liabilities	$180.9K	$658.6K	$497.7K
YoY Change	-37.57%	32.35%	756.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.92M	-$14.02M	-$7.576M
YoY Change	72.98%	85.05%	366.49%
Common Stock	$15.78K	$15.78K	$15.78K
YoY Change	0.0%	0.0%	125.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$21.38K	$21.38K
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.78M	$12.50M	$17.82M
YoY Change
Total Liabilities & Shareholders Equity	$11.96M	$13.16M	$18.32M
YoY Change	-31.28%	-28.19%	1861.62%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity File Number EntityFileNumber	001-41469
	dei	Entity Registrant Name EntityRegistrantName	FORZA X1, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3159685
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3101 S. US-1
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Pierce
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34982
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q2	us-gaap	Salaries And Wages SalariesAndWages	432308	usd
CY2023Q2	us-gaap	Salaries And Wages SalariesAndWages	864838	usd
CY2022Q3	us-gaap	Short Term Lease Payments ShortTermLeasePayments	2500	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	0	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	7500	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	7500	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	11000	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	18281	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	59177	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9533	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	403204	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	27814	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462381	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	172500	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.25
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	306705	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.88
CY2024Q2	FRZA	Warrant Activity WarrantActivity	0	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	476956	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	682980	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.08	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.13	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0298	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0472	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1441500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.41
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15762750	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2981720	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	273076	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	493460	usd
CY2024Q2	FRZA	Due From Affiliates Net Current DueFromAffiliatesNetCurrent	18384	usd
CY2023Q4	FRZA	Due From Affiliates Net Current DueFromAffiliatesNetCurrent	0	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73513	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73508	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	8553852	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	13370219	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	30364	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75147	usd
CY2024Q2	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4565008	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3468961	usd
CY2024Q2	us-gaap	Assets Assets	13156741	usd
CY2023Q4	us-gaap	Assets Assets	16921844	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	503646	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	86820	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	27814	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	462381	usd
CY2024Q2	FRZA	Due To Affiliated Companies Net Current DueToAffiliatedCompaniesNetCurrent	0	usd
CY2023Q4	FRZA	Due To Affiliated Companies Net Current DueToAffiliatedCompaniesNetCurrent	201848	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	24535	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17313	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23073	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68532	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6175	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5700	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	585243	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	842594	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	73400	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	58717	usd
CY2024Q2	us-gaap	Liabilities Liabilities	658643	usd
CY2023Q4	us-gaap	Liabilities Liabilities	901311	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15784000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15754774	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	15784	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	15784	usd
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	29226	shares
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	21379	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	21379	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26523829	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26046873	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14020136	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10020745	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	12498098	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16020533	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13156741	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16921844	usd
CY2024Q2	us-gaap	Revenues Revenues	0	usd
CY2023Q2	us-gaap	Revenues Revenues	0	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	26841	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	40796	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	-26841	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	-40796	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	247464	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	334315	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	340907	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	261473	usd
CY2024Q2	us-gaap	Professional Fees ProfessionalFees	158077	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	69867	usd
CY2024Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1674000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63807	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	48230	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2916563	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1578723	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2943404	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1619519	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	813	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	1493	usd
CY2024Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	112663	usd
CY2023Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	137358	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	245010	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	262268	usd
CY2024Q2	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2023Q2	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	18280	usd
	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	111850	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	135865	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	259352	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	260484	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-2831554	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-1483654	usd
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-3999391	usd
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-3488786	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-2831554	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1483654	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3999391	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3488786	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15754774	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15754774	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11446391	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11446391	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15754774	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15754774	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10950863	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10950863	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13700203	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	341163	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2005132	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12036234	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6929552	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	341817	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-1483654	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	17823949	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16020533	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	293141	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1167837	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	15145837	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	183815	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-2831554	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	12498098	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3999391	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3488786	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	119752	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	83926	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1674000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	476956	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	682980	usd
	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset	44783	usd
	FRZA	Change Of Rightofuse Asset ChangeOfRightofuseAsset	43033	usd
	FRZA	Change In Inventory Reserve ChangeInInventoryReserve	289072	usd
	FRZA	Change In Inventory Reserve ChangeInInventoryReserve	0	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	68688	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	521960	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-360927	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	416826	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-19910	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-434567	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	18777	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-45459	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-42356	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	475	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	500	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1526246	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2882869	usd
	FRZA	Net Redemptions Of Investment In Available For Sale Securities NetRedemptionsOfInvestmentInAvailableForSaleSecurities	3000000	usd
	FRZA	Net Redemptions Of Investment In Available For Sale Securities NetRedemptionsOfInvestmentInAvailableForSaleSecurities	0	usd
	FRZA	Realized Gain On Sale Of Marketable Securities RealizedGainOnSaleOfMarketableSecurities	18280	usd
	FRZA	Realized Gain On Sale Of Marketable Securities RealizedGainOnSaleOfMarketableSecurities	-0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2858227	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	224088	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	123493	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-224088	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6996015	usd
	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	-0	usd
	FRZA	Repayment Of Deferred Offering Costs RepaymentOfDeferredOfferingCosts	66463	usd
	FRZA	Repayments Of Finance Lease RepaymentsOfFinanceLease	9667	usd
	FRZA	Repayments Of Finance Lease RepaymentsOfFinanceLease	7666	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	393969	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	409505	usd
	FRZA	Advances From Affiliates AdvancesFromAffiliates	173737	usd
	FRZA	Advances From Affiliates AdvancesFromAffiliates	343697	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-229899	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6856078	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1632652	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3749121	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9821531	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12767199	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8188879	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16516320	usd
	us-gaap	Interest Paid Net InterestPaidNet	3938	usd
	us-gaap	Interest Paid Net InterestPaidNet	1784	usd
	FRZA	Right Of Use Asset Finance Leases RightOfUseAssetFinanceLeases	31572	usd
	FRZA	Right Of Use Asset Finance Leases RightOfUseAssetFinanceLeases	92405	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1674000	usd
CY2024Q2	us-gaap	Deposit Liability Current DepositLiabilityCurrent	6175	usd
CY2023Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	5700	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zERHli54vt5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"><b><span id="xdx_86E_zuJZ8ASoj9aj">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States “U.S. GAAP” requires management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. Included in those estimates are assumptions about useful life of fixed assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"> </p>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8188879	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zpfRdEh7OBj3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"><b><span id="xdx_863_ztgeazumg7Li">Concentrations of Credit and Business Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_90A_ecustom--FdicInsuredLimit_iI_c20240630_zSTvaKwPQwc8" title="FDIC insured limit">250,000</span> are at risk. At June 30, 2024 and December 31, 2023, the Company had $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20240630_zkbnzDJhPzof" title="FDIC excess amount">7,688,879</span> and $<span id="xdx_906_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zrSvBCjXbev5" title="FDIC excess amount">9,557,799</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"> </p>
CY2024Q2	FRZA	Fdic Insured Limit FdicInsuredLimit	250000	usd
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	7688879	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	9557799	usd
CY2024Q2	us-gaap	Other Inventory OtherInventory	640230	usd
CY2023Q4	us-gaap	Other Inventory OtherInventory	351158	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8188879	usd
CY2024Q2	FRZA	Working Capital WorkingCapital	7968609	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9821531	usd
CY2023Q4	FRZA	Working Capital WorkingCapital	12527625	usd
CY2023Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	6929552	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3999391	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3488786	usd
CY2023Q4	FRZA	Marketable Securities Amortized Cost MarketableSecuritiesAmortizedCost	2930842	usd
CY2023Q4	FRZA	Marketable Securities Gross Unrealized Gains MarketableSecuritiesGrossUnrealizedGains	50878	usd
CY2023Q4	FRZA	Marketable Securities Gross Unrealized Losses MarketableSecuritiesGrossUnrealizedLosses	0	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	2981720	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	2981720	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4919171	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3703373	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	354163	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	234412	usd
CY2024Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	4565008	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	3468961	usd
CY2024Q2	us-gaap	Depreciation Depreciation	63807	usd
CY2023Q2	us-gaap	Depreciation Depreciation	48230	usd
	us-gaap	Depreciation Depreciation	119752	usd
	us-gaap	Depreciation Depreciation	83926	usd
CY2022Q4	FRZA	Treasury Stock Acquired Average Cost Precentage TreasuryStockAcquiredAverageCostPrecentage	0.0033	pure
CY2022Q4	us-gaap	Payments For Rent PaymentsForRent	7742	usd
CY2024Q2	us-gaap	Security Deposit SecurityDeposit	7517	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	30364	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75147	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23073	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68532	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	23073	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	68532	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	23226	usd
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P0Y18D
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	23226	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	153	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	23073	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.04	pure
CY2024Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P0Y3M14D
CY2023Q1	FRZA	Net Asset Value NetAssetValue	48826	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.030	pure
CY2023Q1	FRZA	Net Asset Value NetAssetValue	43579	usd
CY2023Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2024Q1	FRZA	Net Asset Value NetAssetValue	33393	usd
CY2024Q1	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P60M
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	24535	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	73400	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	14466	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	28931	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	28931	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	28931	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	6384	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	107643	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	9708	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	97935	usd
CY2024Q2	FRZA	Due From Affiliates Net Current DueFromAffiliatesNetCurrent	18384	usd
CY2023Q4	FRZA	Due To Affiliated Companies Net Current DueToAffiliatedCompaniesNetCurrent	201848	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	393969	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	409505	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	173737	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	343697	usd
CY2022Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4009913	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	518000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.70
CY2023	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P9Y9M3D
CY2023	FRZA	Fair Value Of Option Granted FairValueOfOptionGranted	287835	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	69583	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.24
CY2023	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm2	P9Y7M13D
CY2023	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited	-40248	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1889917	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.72
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P9Y4M9D
CY2023Q4	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	4257500	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	521843	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1.50
	FRZA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm2	P8Y11M19D
	FRZA	Fair Value Of Option Forfeited FairValueOfOptionForfeited	-2079516	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1368074	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.72
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y6M7D
CY2024Q2	FRZA	Fair Value Of Option Outstanding FairValueOfOptionOutstanding	2177984	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	411500	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.39
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y4M2D
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1674000	usd
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001731122-24-001255-index-headers.html	Edgar Link	pending
0001731122-24-001255-index.html	Edgar Link	pending
0001731122-24-001255.txt	Edgar Link	pending
0001731122-24-001255-xbrl.zip	Edgar Link	pending
e5869_10q.htm	Edgar Link	pending
e5869_ex31-1.htm	Edgar Link	pending
e5869_ex31-2.htm	Edgar Link	pending
e5869_ex32-1.htm	Edgar Link	pending
e5869_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
frza-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
e5869_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
frza-20240630_cal.xml	Edgar Link	unprocessable
frza-20240630_def.xml	Edgar Link	unprocessable
frza-20240630_lab.xml	Edgar Link	unprocessable
frza-20240630_pre.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Forza X1, Inc.

2024 Q3 Form 10-Q Financial Statement

#000173112224001255 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission